Inflammation markers such as Interleukin-6 (IL-6), C-reactive protein (CRP), and others are associated with both increased asthma exacerbations and cardiovascular events.23,24 The role of type 2 inflammation in atherosclerosis is garnering attention.25 Consequently, eosinophil granulocytes, as effectors of the type 2 inflammation cascade, have become the focus in several cardiovascular studies. This evidence concerns the gene CRP and asthma.